BSE - Delayed Quote INR

Ambuja Cements Limited (AMBUJACEM.BO)

535.05
0.00
(0.00%)
At close: 3:29:46 PM GMT+5:30
Loading Chart for AMBUJACEM.BO
  • Previous Close 535.05
  • Open 524.75
  • Bid 534.85 x --
  • Ask 535.20 x --
  • Day's Range 524.75 - 538.45
  • 52 Week Range 452.90 - 706.85
  • Volume 419,408
  • Avg. Volume 163,195
  • Market Cap (intraday) 1.318T
  • Beta (5Y Monthly) -0.07
  • PE Ratio (TTM) 31.55
  • EPS (TTM) 16.96
  • Earnings Date Jul 29, 2025 - Aug 2, 2025
  • Forward Dividend & Yield 2.00 (0.37%)
  • Ex-Dividend Date Jun 12, 2025
  • 1y Target Est 614.31

Ambuja Cements Limited, together with its subsidiaries, manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. The company offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. It sells its products through dealers, authorized retail stockiest, retailers, and authorized sales representatives. The company was formerly known as Gujarat Ambuja Cements Limited and changed its name to Ambuja Cements Limited in April 2007. The company was incorporated in 1981 and is based in Ahmedabad, India. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.

www.ambujacement.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: AMBUJACEM.BO

View More

Performance Overview: AMBUJACEM.BO

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

AMBUJACEM.BO
0.08%
S&P BSE SENSEX (^BSESN)
3.34%

1-Year Return

AMBUJACEM.BO
9.58%
S&P BSE SENSEX (^BSESN)
9.84%

3-Year Return

AMBUJACEM.BO
46.95%
S&P BSE SENSEX (^BSESN)
47.25%

5-Year Return

AMBUJACEM.BO
251.83%
S&P BSE SENSEX (^BSESN)
156.80%

Compare To: AMBUJACEM.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMBUJACEM.BO

View More

Valuation Measures

As of 5/6/2025
  • Market Cap

    1.32T

  • Enterprise Value

    1.23T

  • Trailing P/E

    31.55

  • Forward P/E

    31.45

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.90

  • Price/Book (mrq)

    2.47

  • Enterprise Value/Revenue

    3.64

  • Enterprise Value/EBITDA

    14.24

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.89%

  • Return on Assets (ttm)

    2.98%

  • Return on Equity (ttm)

    9.00%

  • Revenue (ttm)

    350.45B

  • Net Income Avi to Common (ttm)

    41.67B

  • Diluted EPS (ttm)

    16.96

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    79.94B

  • Total Debt/Equity (mrq)

    1.24%

  • Levered Free Cash Flow (ttm)

    -43.51B

Research Analysis: AMBUJACEM.BO

View More

People Also Watch